Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Support Care Cancer. 2015 Oct 5;24(4):1729–1753. doi: 10.1007/s00520-015-2946-8

Table 6. Site C high satisfaction with care (median cut-off) by demographics.

Independent variable Diagnostic resolution Cancer treatment


High satisfaction (n=50) Not high satisfaction (n=73) High satisfaction (n=0) Not high satisfaction (n=0)
Group allocation
 Control 2.00 % (1) 1.37 % (1)
 Patient navigation 98.00 % (49) 98.63 % (72)
Gender
 Female 0.00 % (0) 0.00 % (0)
 Male 100.0 % (50) 100.0 % (73)
Age categorized
 <40 0.00 % (0) 0.00 % (0)
 40–<49 0.00 % (0) 2.74 % (2)
 50–<60 30.00 % (15) 20.55 % (15)
 60+ 70.00 % (35) 76.71 % (56)
Race/ethnicity
 Black 60.00 % (30) 63.01 % (46)
 White 36.00 % (18) 27.40 % (20)
 Hispanic 4.00 % (2) 6.85 % (5)
 Other 0.00 % (0) 2.74 % (2)
Primary language
 English 98.00 % (49) 95.89 % (70)
 Other 2.00 % (1) 4.11 % (3)
Birth country
 Outside of USA 2.00 % (1) 5.48 % (4)
 USA 98.00 % (49) 94.52 % (69)
Education
 Less than high school 12.00 % (6) 9.59 % (7)
 High school diploma 22.00 % (11) 28.77 % (21)
 Some college/associate 54.00 % (27) 50.68 % (37)
 College grad/professional 12.00 % (6) 10.96 % (8)
Median household income by ZIP
 Less than $30,000 16.00 % (8) 29.17 % (21)
 $30,000 to 39,999 30.00 % (15) 31.94 % (23)
 $40,000 to 49,999 26.00 % (13) 15.28 % (11)
 $50,000 or more 28.00 % (14) 23.61 % (17)
Insurance status
 Uninsured 0.00 % (0) 0.00 % (0)
 Public 78.00 % (39) 79.45 % (58)
 Private 22.00 % (11) 20.55 % (15)
Employment status
 Unemployed 58.00 % (29) 76.39 % (55)
 Part-time 14.00 % (7) 9.72 % (7)
 Full-time 28.00 % (14) 13.89 % (10)
Housing status
 Renting 44.00 % (22) 31.94 % (23)
 Own home 48.00 % (24) 58.33 % (42)
 Other 8.00 % (4) 9.72 % (7)
Distance
 <1.5 0.00 % (0) 1.37 % (1)
 1.5–<4.0 10.00 % (5) 6.85 % (5)
 4–<8.5 20.00 % (10) 17.81 % (13)
 8.5+ 70.00 % (35) 73.97 % (54)
Cancer site
 Breast 0.00 % (0) 0.00 % (0)
 Cervix 0.00 % (0) 0.00 % (0)
 Colorectal 0.00 % (0) 0.00 % (0)
 Prostate 100.0 % (50) 100.0 % (73)
Stage
 Stage 0
 Stage 1
 Stage 2
 Stage 3
 Stage 4
 CIN2 or CIN3